The Department of Veterans Affairs intends to award a sole source contract to Bayer Healthcare for the procurement of updated CT and MRI injectors at the Syracuse VAMC. This decision aims to replace aging injectors essential for maintaining operational services and avoiding disruptions. The CT injector is required to inject contrast and saline during examinations, while the MRI injector must comply with nonferrous material standards to work safely with magnetic environments. Additionally, the new portable and operating room hybrid injectors need to integrate with sterile syringe systems to prevent infection during vascular procedures. This procurement emphasizes consistency in materials and procedural safety to ensure efficient medical services. The contract solicitation requests responses by April 2, 2025, and is not open for competitive bids.

The document outlines a request for justification for a single-source acquisition by the Department of Veterans Affairs for dual CT injectors essential for maintaining services at the Syracuse Medical Center. The estimated cost is $194,604, aimed at upgrading outdated injectors to ensure consistency with existing equipment from Bayer, which already services most of the facility's requirements. The injectors are critical for the smooth operation of the CT, MRI, and Interventional Radiology departments, delivering IV contrast at precise rates crucial for diagnostic imaging. Market research indicated no other viable sources apart from Bayer, confirming the need for standardization within the department. The contracting officer, Corey Swinton, certifies the justification’s accuracy and the decision's compliance with federal acquisition regulations. This document serves as a formal rationale for pursuing a single-source award, emphasizing the unique attributes of the injectors and the lack of alternative suppliers.